BACKGROUND: Single-nucleotide polymorphisms (SNPs) in 2 distinct regions of the gene for the sortilin-related receptor (SORL1) (bounded by consecutively numbered SNPs 8-10 and 22-25) were shown to be associated with Alzheimer disease (AD) in multiple ethnically diverse samples. OBJECTIVE: To test the hypothesis that SORL1 is associated with brain magnetic resonance imaging (MRI) measurements of atrophy and/or vascular disease. DESIGN, SETTING, AND PATIENTS: We evaluated the association of 30 SNPs spanning SORL1 with MRI measures of general cerebral atrophy, hippocampal atrophy, white matter hyperintensities, and overall cerebrovascular disease in 44 African American and 182 white sibships from the MIRAGE Study. We performed single- and 3-SNP haplotype association analyses using family-based tests. Haplotypes found to be significantly associated with at least 1 MRI trait were tested for association with 6 pathological traits in a separate sample of 69 white patients with autopsy-confirmed AD. RESULTS: In white patients, white matter hyperintensities were associated with multiple markers in the region encompassing SNPs 6 to 10, whereas cerebral and hippocampal atrophy were associated with markers from the region including SNPs 21 to 26. Examination of specific 3-SNP haplotypes from these 2 regions in the autopsy-confirmed cases of AD revealed association of white matter disease with SNPs 8 to 10 and association of hippocampal atrophy with SNPs 22 to 26. The haplotype CGC at SNPs 8 to 10 was associated with fewer white matter changes in the clinical (P<.001) and autopsy (P=.02) samples. CONCLUSIONS: Variants of SORL1 previously associated with AD are also associated with MRI and neuropathological measures of neurodegenerative and cerebrovascular disease. These findings not only support the hypothesis that multiple areas in SORL1 are of functional importance but also raise the possibility that multiple SORL1 variants influence amyloid precursor protein or endothelial lipoprotein processing or both in different regions of the brain.
BACKGROUND: Single-nucleotide polymorphisms (SNPs) in 2 distinct regions of the gene for the sortilin-related receptor (SORL1) (bounded by consecutively numbered SNPs 8-10 and 22-25) were shown to be associated with Alzheimer disease (AD) in multiple ethnically diverse samples. OBJECTIVE: To test the hypothesis that SORL1 is associated with brain magnetic resonance imaging (MRI) measurements of atrophy and/or vascular disease. DESIGN, SETTING, AND PATIENTS: We evaluated the association of 30 SNPs spanning SORL1 with MRI measures of general cerebral atrophy, hippocampal atrophy, white matter hyperintensities, and overall cerebrovascular disease in 44 African American and 182 white sibships from the MIRAGE Study. We performed single- and 3-SNP haplotype association analyses using family-based tests. Haplotypes found to be significantly associated with at least 1 MRI trait were tested for association with 6 pathological traits in a separate sample of 69 white patients with autopsy-confirmed AD. RESULTS: In white patients, white matter hyperintensities were associated with multiple markers in the region encompassing SNPs 6 to 10, whereas cerebral and hippocampal atrophy were associated with markers from the region including SNPs 21 to 26. Examination of specific 3-SNP haplotypes from these 2 regions in the autopsy-confirmed cases of AD revealed association of white matter disease with SNPs 8 to 10 and association of hippocampal atrophy with SNPs 22 to 26. The haplotype CGC at SNPs 8 to 10 was associated with fewer white matter changes in the clinical (P<.001) and autopsy (P=.02) samples. CONCLUSIONS: Variants of SORL1 previously associated with AD are also associated with MRI and neuropathological measures of neurodegenerative and cerebrovascular disease. These findings not only support the hypothesis that multiple areas in SORL1 are of functional importance but also raise the possibility that multiple SORL1 variants influence amyloid precursor protein or endothelial lipoprotein processing or both in different regions of the brain.
Authors: Ekaterina Rogaeva; Yan Meng; Joseph H Lee; Yongjun Gu; Toshitaka Kawarai; Fanggeng Zou; Taiichi Katayama; Clinton T Baldwin; Rong Cheng; Hiroshi Hasegawa; Fusheng Chen; Nobuto Shibata; Kathryn L Lunetta; Raphaelle Pardossi-Piquard; Christopher Bohm; Yosuke Wakutani; L Adrienne Cupples; Karen T Cuenco; Robert C Green; Lorenzo Pinessi; Innocenzo Rainero; Sandro Sorbi; Amalia Bruni; Ranjan Duara; Robert P Friedland; Rivka Inzelberg; Wolfgang Hampe; Hideaki Bujo; You-Qiang Song; Olav M Andersen; Thomas E Willnow; Neill Graff-Radford; Ronald C Petersen; Dennis Dickson; Sandy D Der; Paul E Fraser; Gerold Schmitt-Ulms; Steven Younkin; Richard Mayeux; Lindsay A Farrer; Peter St George-Hyslop Journal: Nat Genet Date: 2007-01-14 Impact factor: 38.330
Authors: H Yamazaki; H Bujo; J Kusunoki; K Seimiya; T Kanaki; N Morisaki; W J Schneider; Y Saito Journal: J Biol Chem Date: 1996-10-04 Impact factor: 5.157
Authors: M Yoshita; E Fletcher; D Harvey; M Ortega; O Martinez; D M Mungas; B R Reed; C S DeCarli Journal: Neurology Date: 2006-12-26 Impact factor: 9.910
Authors: Katrin Offe; Sara E Dodson; James T Shoemaker; Jason J Fritz; Marla Gearing; Allan I Levey; James J Lah Journal: J Neurosci Date: 2006-02-01 Impact factor: 6.167
Authors: Qiang Liu; Celina V Zerbinatti; Juan Zhang; Hyang-Sook Hoe; Baiping Wang; Sarah L Cole; Joachim Herz; Louis Muglia; Guojun Bu Journal: Neuron Date: 2007-10-04 Impact factor: 17.173
Authors: Joseph H Lee; Rong Cheng; Nicole Schupf; Jennifer Manly; Rafael Lantigua; Yaakov Stern; Ekaterina Rogaeva; Yosuke Wakutani; Lindsay Farrer; Peter St George-Hyslop; Richard Mayeux Journal: Arch Neurol Date: 2007-04
Authors: Julie A Schneider; Patricia A Boyle; Zoe Arvanitakis; Julia L Bienias; David A Bennett Journal: Ann Neurol Date: 2007-07 Impact factor: 10.422
Authors: Kathryn L Lunetta; Porat M Erlich; Karen T Cuenco; L Adrienne Cupples; Robert C Green; Lindsay A Farrer; Charles Decarli Journal: Alzheimer Dis Assoc Disord Date: 2007 Apr-Jun Impact factor: 2.703
Authors: Sudha Seshadri; Anita L DeStefano; Rhoda Au; Joseph M Massaro; Alexa S Beiser; Margaret Kelly-Hayes; Carlos S Kase; Ralph B D'Agostino; Charles Decarli; Larry D Atwood; Philip A Wolf Journal: BMC Med Genet Date: 2007-09-19 Impact factor: 2.103
Authors: Andrew J Saykin; Li Shen; Tatiana M Foroud; Steven G Potkin; Shanker Swaminathan; Sungeun Kim; Shannon L Risacher; Kwangsik Nho; Matthew J Huentelman; David W Craig; Paul M Thompson; Jason L Stein; Jason H Moore; Lindsay A Farrer; Robert C Green; Lars Bertram; Clifford R Jack; Michael W Weiner Journal: Alzheimers Dement Date: 2010-05 Impact factor: 21.566
Authors: Scott A Melville; Jacqueline Buros; Antonio R Parrado; Badri Vardarajan; Mark W Logue; Li Shen; Shannon L Risacher; Sungeun Kim; Gyungah Jun; Charles DeCarli; Kathryn L Lunetta; Clinton T Baldwin; Andrew J Saykin; Lindsay A Farrer Journal: Ann Neurol Date: 2012-06-28 Impact factor: 10.422
Authors: Chandra A Reynolds; Catalina Zavala; Margaret Gatz; Loryana Vie; Boo Johansson; Bo Malmberg; Erik Ingelsson; Jonathan A Prince; Nancy L Pedersen Journal: Neurobiol Aging Date: 2013-01-11 Impact factor: 4.673
Authors: Karen T Cuenco; Robert Friedland; Clinton T Baldwin; Jianping Guo; Badri Vardarajan; Kathryn L Lunetta; L Adrienne Cupples; Robert C Green; Charles DeCarli; Lindsay A Farrer Journal: Neurobiol Aging Date: 2009-03-27 Impact factor: 4.673